PTC
ABVX icon

Private Trust Company’s Abivax ABVX Stock Holding History

Private Trust Company’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Buy
110
+23
+26% +$2.6K ﹤0.01% 1930
2026
Q1 		$9.69K Buy
87
+60
+222% +$7.1K ﹤0.01% 1991
2025
Q4 		$3.64K Sell
27
-43
-61% -$4.69K ﹤0.01% 2243
2025
Q3 		$5.94K Buy
+70
New +$4.29K ﹤0.01% 2100

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Private Trust Company's ABVX Position: Q2 2026 in Review

Private Trust Company increased its Abivax (ABVX) stake by 26% in Q2 2026, buying an estimated $2.6K and bringing the position to 110 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1930.

Private Trust Company first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Private Trust Company held 110 shares of Abivax worth $14.7K as of Q2 2026.
  • Private Trust Company bought 23 Abivax shares in Q2 2026, an estimated $2.6K.
  • Abivax made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #1930 holding.
  • Private Trust Company first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.